世界のベアメタルステント(BMS)市場:医療機器パイプライン分析2016

◆英語タイトル:Bare Metal Stents (BMS) - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0211EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年7月4日
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、ベアメタルステント(BMS)のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・ベアメタルステント(BMS)の概要
・ベアメタルステント(BMS)の開発動向:開発段階別分析
・ベアメタルステント(BMS)の開発動向:セグメント別分析
・ベアメタルステント(BMS)の開発動向:領域別分析
・ベアメタルステント(BMS)の開発動向:規制Path別分析
・ベアメタルステント(BMS)の開発動向:承認日(推定)別分析
・企業別ベアメタルステント(BMS)の開発動向(パイプライン製品、進行中の治験)
・ベアメタルステント(BMS)の最近動向
【レポートの概要】

Bare Metal Stents (BMS) – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Bare Metal Stents (BMS) – Medical Devices Pipeline Assessment, 2016″ provides an overview of Bare Metal Stents (BMS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bare Metal Stents (BMS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bare Metal Stents (BMS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bare Metal Stents (BMS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Bare Metal Stents (BMS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Bare Metal Stents (BMS) Overview 7
3 Products under Development 8
3.1 Bare Metal Stents (BMS) – Pipeline Products by Stage of Development 8
3.2 Bare Metal Stents (BMS) – Pipeline Products by Territory 9
3.3 Bare Metal Stents (BMS) – Pipeline Products by Regulatory Path 10
3.4 Bare Metal Stents (BMS) – Pipeline Products by Estimated Approval Date 11
3.5 Bare Metal Stents (BMS) – Ongoing Clinical Trials 12
4 Bare Metal Stents (BMS) – Pipeline Products under Development by Companies 13
4.1 Bare Metal Stents (BMS) Companies – Pipeline Products by Stage of Development 13
4.2 Bare Metal Stents (BMS) – Pipeline Products by Stage of Development 14
5 Bare Metal Stents (BMS) Companies and Product Overview 15
5.1 AlviMedica Medical Technologies Inc. Company Overview 15
5.1.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Atrium Medical Corporation Company Overview 19
5.2.1 Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Biotronik SE & Co. KG Company Overview 20
5.3.1 Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Bolton Medical, Inc. Company Overview 22
5.4.1 Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Boston Scientific Corporation Company Overview 23
5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 InspireMD, Inc. Company Overview 27
5.6.1 InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 ITGI Medical Ltd. Company Overview 30
5.7.1 ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Medtronic plc Company Overview 31
5.8.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Meril Life Sciences Pvt. Ltd. Company Overview 33
5.9.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 MIV Therapeutics Inc Company Overview 36
5.10.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.11 Nesstent Ltd. Company Overview 37
5.11.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
5.12 Nexeon MedSystems, Inc. Company Overview 38
5.12.1 Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.13 Palmaz Scientific, Inc. Company Overview 41
5.13.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Qvanteq AG Company Overview 42
5.14.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 42
5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 45
5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 45
5.16 Stentys SA Company Overview 46
5.16.1 Stentys SA Pipeline Products & Ongoing Clinical Trials Overview 46
5.17 Svelte Medical Systems, Inc. Company Overview 48
5.17.1 Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.18 Vascular Concepts Limited Company Overview 50
5.18.1 Vascular Concepts Limited Pipeline Products & Ongoing Clinical Trials Overview 50
6 Bare Metal Stents (BMS)- Recent Developments 54
6.1 Jun 29, 2016: InspireMD Prices Public Offering of Preferred Stock and Warrants for USD14.6 Million 54
6.2 Jun 17, 2016: ARIAD Completes Strategic Review and Announces Plans for Growth 54
6.3 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 55
6.4 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 55
6.5 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 56
6.6 May 24, 2016: ARIAD Announces Appointment of Jennifer L. Herron as Chief Commercial Officer 58
6.7 May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 59
6.8 May 10, 2016: ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review 60
6.9 May 02, 2016: B. Braun Interventional Systems Extends Exclusive U.S. Distribution Agreement with NuMED 62
6.10 Apr 20, 2016: Abbott Reports First-Quarter 2016 Results 62
6.11 Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes “Shanghai-Yizheng Healthcare Cooperation Project” 65
6.12 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 65
6.13 Mar 21, 2016: NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient 65
6.14 Jan 28, 2016: STENTYS: First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs Broadcasted Live at LINC International Congress 66
6.15 Nov 21, 2015: The Registration has been approved in Philippines for WALTZ Cobalt Alloy Stent System 66
6.16 Oct 21, 2015: Abbott Reports Third-Quarter 2015 Results 67
6.17 Aug 03, 2015: Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 68
6.18 Jul 22, 2015: Abbott Reports Second-Quarter 2015 Results 69
7 Appendix 72
7.1 Methodology 72
7.2 About GlobalData 74
7.3 Contact Us 75
7.4 Disclaimer 75

1.1 List of Tables
Table 1: Bare Metal Stents (BMS) - Pipeline Products by Stage of Development 8
Table 2: Bare Metal Stents (BMS) - Pipeline Products by Territory 9
Table 3: Bare Metal Stents (BMS) - Pipeline Products by Regulatory Path 10
Table 4: Bare Metal Stents (BMS) - Pipeline Products by Estimated Approval Date 11
Table 5: Bare Metal Stents (BMS) - Ongoing Clinical Trials 12
Table 6: Bare Metal Stents (BMS) Companies - Pipeline Products by Stage of Development 13
Table 7: Bare Metal Stents (BMS) - Pipeline Products by Stage of Development 14
Table 8: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: BMS - Avantgarde - Product Status 15
Table 10: BMS - Avantgarde - Product Description 16
Table 11: BMS - Chrono - Product Status 16
Table 12: BMS - Chrono - Product Description 17
Table 13: Tecnic Plus - Product Status 17
Table 14: Tecnic Plus - Product Description 18
Table 15: Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 19
Table 16: Next Generation Super Flexible Cobalt Chromium Coronary Stent - Product Status 19
Table 17: Next Generation Super Flexible Cobalt Chromium Coronary Stent - Product Description 19
Table 18: Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 20
Table 19: AMS-1 - Product Status 20
Table 20: AMS-1 - Product Description 20
Table 21: AMS-2 - Product Status 21
Table 22: AMS-2 - Product Description 21
Table 23: Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 24: Spiral Force - Product Status 22
Table 25: Spiral Force - Product Description 22
Table 26: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
Table 27: INNOVA Self-Expanding Bare-Metal Stent System - Product Status 23
Table 28: INNOVA Self-Expanding Bare-Metal Stent System - Product Description 24
Table 29: Boston Scientific Corporation - Ongoing Clinical Trials Overview 25
Table 30: INNOVA Self-Expanding Bare-Metal Stent System - Korean Multicenter Registry of INNOVA Stent for Femoropopliteal Artery Disease: (K-INNOVA Registry) 26
Table 31: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 32: MGuard Prime EPS - Product Status 28
Table 33: MGuard Prime EPS - Product Description 29
Table 34: ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 35: Aneugraft Dx - Product Status 30
Table 36: Aneugraft Dx - Product Description 30
Table 37: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 38: Twin-Rail - Product Status 31
Table 39: Twin-Rail - Product Description 32
Table 40: Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 41: Crypton Stainless Steel Coronary Stent System - Product Status 33
Table 42: Crypton Stainless Steel Coronary Stent System - Product Description 34
Table 43: NEXGEN Cobalt Chromium Coronary Stent System - Product Status 34
Table 44: NEXGEN Cobalt Chromium Coronary Stent System - Product Description 35
Table 45: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 46: Vestapor - Product Status 36
Table 47: Vestapor - Product Description 36
Table 48: Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 49: NesStent's New Stent - Product Status 37
Table 50: NesStent's New Stent - Product Description 37
Table 51: Nexeon MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 52: PROTEX Coronary Stent System - Product Status 38
Table 53: PROTEX Coronary Stent System - Product Description 39
Table 54: RIVIERA Coronary Stent System - Product Status 39
Table 55: RIVIERA Coronary Stent System - Product Description 40
Table 56: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 57: Micro-Grooved Coronary Stent - Product Status 41
Table 58: Micro-Grooved Coronary Stent - Product Description 41
Table 59: Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 42
Table 60: Qstent - Product Status 42
Table 61: Qstent - Product Description 42
Table 62: Qvanteq AG - Ongoing Clinical Trials Overview 43
Table 63: Qstent - Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation 44
Table 64: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 45
Table 65: Bare Metal Coronary Stent - Product Status 45
Table 66: Bare Metal Coronary Stent - Product Description 45
Table 67: Stentys SA Pipeline Products & Ongoing Clinical Trials Overview 46
Table 68: STENTYS Self-Apposing Coronary Stent - Product Status 46
Table 69: STENTYS Self-Apposing Coronary Stent - Product Description 47
Table 70: Svelte Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 71: Svelte Acrobat System - Product Status 48
Table 72: Svelte Acrobat System - Product Description 49
Table 73: Vascular Concepts Limited Pipeline Products & Ongoing Clinical Trials Overview 50
Table 74: ProLink LP - Product Status 50
Table 75: ProLink LP - Product Description 51
Table 76: ProLink SV - Product Status 51
Table 77: ProLink SV - Product Description 51
Table 78: ProPass - Product Status 52
Table 79: ProPass - Product Description 52
Table 80: ProZeta - Product Status 52
Table 81: ProZeta - Product Description 53
Table 82: Glossary 73

1.2 List of Figures
Figure 1: Bare Metal Stents (BMS) - Pipeline Products by Stage of Development 8
Figure 2: Bare Metal Stents (BMS) - Pipeline Products by Territory 9
Figure 3: Bare Metal Stents (BMS) - Pipeline Products by Regulatory Path 10
Figure 4: Bare Metal Stents (BMS) - Pipeline Products by Estimated Approval Date 11
Figure 5: Bare Metal Stents (BMS) - Ongoing Clinical Trials 12

【掲載企業】

AlviMedica Medical Technologies Inc.
Atrium Medical Corporation
Biotronik SE & Co. KG
Bolton Medical, Inc.
Boston Scientific Corporation
InspireMD, Inc.
ITGI Medical Ltd.
Medtronic plc
Meril Life Sciences Pvt. Ltd.
MIV Therapeutics Inc
Nesstent Ltd.
Nexeon MedSystems, Inc.
Palmaz Scientific, Inc.
Qvanteq AG
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stentys SA
Svelte Medical Systems, Inc.
Vascular Concepts Limited

★調査レポート[世界のベアメタルステント(BMS)市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界のベアメタルステント(BMS)市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆